In prostate cancer cells, DLGAP5 has been proved to be poorly expressed in hypoxic environments and has predictive value for the prognosis of prostate cancer patients  (Espinoza et al., 2016; Gomez et al., 2013). Here, DLGAP5 is linked to prostate carcinoma.